Newest research in dermatology and venereology, interviews with notable doctors, professors and researchers: a focused look on today's dermatology and new developments looking to the future.
E44: Editor’s Picks November 2021
Join us as we go through the JEADV Editor's Picks of November 2021:
(1) Long-term safety data for a monoclonal antibody used in psoriasis
(2) Preventing anaphylactoid symptoms following Covid-19 vaccination
(3) Innovative surgery option for bromhidrosis
(4) Surprising trends in syphilis
Read the editor's picks here:
E43: The Evolving Field of Dermato-oncology: A License to Examine
This week EADV Advocacy Working Group Leader Myrto Trakatelli talks with Stella Siskou about topics including EPIDERM, the EADV Advocacy Working Group, and a position paper on the role of dermatologists in the evolving field of Dermato-oncology.
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Force
E42: Changing Treatment Landscape in Psoriasis
This week Dr. Mark Lebwohl from Icahn School of Medicine at Mount Sinai joins us to discuss the latest treatment options for psoriasis and his research focusing on new topical therapies for the management of the disease.
Links to the six articles discussed can be found here:
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial
Secukinumab maintains superiority over ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: 52-week results from a double-blind phase 3b trial (CLARITY)
Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER-3 study
Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion inmoderate-to-severe plaque psoriasis: phase 3 open-label study
Itch: an under-recognized problem in psoriasis
E41: Editor‘s Picks October 2021
Join us as we go through the JEADV Editor's Picks of October 2021:
(1) Are skin types equally represented in Scandinavian dermatology textbooks?
(2) Apremilast for palmoplantar pustulosis under study
(3) The link between autoimmune bullous diseases and neurological diseases
(4) Investigating the cancer risk of using a biologic drug in atopic dermatitis
Read the editor's picks here:
E40: Pemphigus Vulgaris and Foliaceus: Latest management advancements
This week esteemed Professor Branka Marinović shares her experience as Secretary General of the EADV (2017-2021) and reflects on some significant ways how the Academy has changed in the past years. Join us as Prof. Marinovic talks about how the “Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus” facilitated the everyday work of Dermatologists and improved quality of care. Finally, the importance of collaboration between the Autoimmune Blistering Diseases Task Force of the EADV and patient organizations is also highlighted.
The guidelines can be read here: Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the EADV
E39: Life on the Ocean Wave: Success of a targeted skin cancer screening programme
This month we discuss a recent publication reporting on the success of a targeted skin cancer screening initiative at a sailing festival with author Professor Khosrotehrani, a clinician-scientist and dermatologist at the University of Queensland, and the Diamantina Institute, Brisbane. Listen as moderator Dr Sarah Walsh explores the challenges and implications of delivering such a screening programme in the unique location of Hamilton Island, off the coast of Queensland.
Read all about this interesting subject here:
💡Did you know that a subscription to the high-impact factor JEADV is included in the EADV Membership?